Experimental browser for the Atmosphere
I look at the business side of things: namely, is there still a market for new COVID-19 drugs? In the words of Lawrence Blatt, CEO of Aligos Therapeutics, “I always like to say, ‘You think you’re done with COVID, but COVID is not done with you.’ ” cen.acs.org/pharmaceutic...
Mar 10, 2025, 2:19 PM
{ "uri": "at://did:plc:3uftzaq35i646we5kd4id2ob/app.bsky.feed.post/3ljzqpgzd3m26", "cid": "bafyreif5sda5xh2iyikreiw6gpybqmc3z27xmhbsgjib3zmgmx3mra3o2u", "value": { "text": "I look at the business side of things: namely, is there still a market for new COVID-19 drugs?\n\nIn the words of Lawrence Blatt, CEO of Aligos Therapeutics, “I always like to say, ‘You think you’re done with COVID, but COVID is not done with you.’ ” cen.acs.org/pharmaceutic...", "$type": "app.bsky.feed.post", "embed": { "$type": "app.bsky.embed.external", "external": { "uri": "https://cen.acs.org/pharmaceuticals/market-new-COVID-19-drugs/103/i6", "thumb": { "$type": "blob", "ref": { "$link": "bafkreic6pw66yji4aq3dl65o25s7eoijsbtxxc5ftykkxyukeqk4b7br3y" }, "mimeType": "image/jpeg", "size": 723582 }, "title": "Is there a market for new COVID-19 drugs?", "description": "Waning interest in the virus has drugmakers trying for new angles" } }, "langs": [ "en" ], "reply": { "root": { "cid": "bafyreifob6wziyjjruaqtwy66t2lo63ffseb5yb3rgs3ogclgdo5maquqi", "uri": "at://did:plc:3uftzaq35i646we5kd4id2ob/app.bsky.feed.post/3ljzqpfolvk26" }, "parent": { "cid": "bafyreihtnp3uowumh2yar45beseobb54ov3h3ypdhypjrohypttw7fcrfm", "uri": "at://did:plc:3uftzaq35i646we5kd4id2ob/app.bsky.feed.post/3ljzqpgoobe26" } }, "facets": [ { "index": { "byteEnd": 288, "byteStart": 261 }, "features": [ { "uri": "https://cen.acs.org/pharmaceuticals/market-new-COVID-19-drugs/103/i6", "$type": "app.bsky.richtext.facet#link" } ] } ], "createdAt": "2025-03-10T14:19:57.837Z" } }